Clinical Trials

680 enrolled

Carcinoma, Hepatocellular

NCT07392892 2026-04-13

A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

840 enrolled

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT06989437 2026-04-08

A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue

982 enrolled

Phase 2/3 Enrolling by invitation

Anorexia, Cachexia, Fatigue, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Weight Loss

NCT06506955 2026-04-03

Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.

15 enrolled

Neoplasm Metastasis, Cholangiocarcinoma

NCT07221149 2026-04-02

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

690 enrolled

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT07076121 2026-03-31

A Study Comparing BMS-986504 in Combination With Nab-paclitaxel and Gemcitabine Versus Placebo in Combination With Nab-paclitaxel and Gemcitabine in Participants With Untreated Metastatic Pancreatic Ductal Adenocarcinoma With Homozygous MTAP Deletion (MountainTAP-30)

470 enrolled

Pancreatic Neoplasms

NCT07221357 2026-03-31

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

990 enrolled

Colorectal Neoplasms

NCT07462143 2026-03-10

A Phase Ⅱ/Ⅲ Clinical Trial of RC148 Plus Chemotherapy as 1L Therapy for Unresectable or Metastatic Colorectal Cancer

700 enrolled

Colonic Neoplasms

NCT07454720 2026-03-06

A Randomized, Double-blind, Placebo-controlled, Multicenter Phase II/III Clinical Study of Adebrelimab in Combination With SHR-8068 and Chemoradiotherapy as Perioperative Therapy for Locally Advanced Rectal Cancer

165 enrolled

Locally Advanced Resectable Rectal Cancer

NCT07392866 2026-02-09

A Clinical Study of SH006 Injection in Combination Therapy Versus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma

120 enrolled

Carcinoma, Hepatocellular

NCT07379047 2026-01-30

GISTAR-1

255 enrolled

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT07332533 2026-01-12

A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer

490 enrolled

HER2-positive Gastric Cancer

NCT07321847 2026-01-07

INJECTABL-3

717 enrolled

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04353375 2025-12-31

HMPL-453 Tartrate in Advanced Intrahepatic Cholangiocarcinoma

GastrointestinalOther solid neoplasm

235 enrolled

Advanced Intrahepatic Cholangiocarcinoma

NCT06361888 2025-12-30

A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer

502 enrolled

Pancreatic Neoplasms

NCT07251062 2025-11-26

A Study of SYS6010, Enlonstobart, and Chemotherapy for First-Line Treatment of Esophageal Squamous Cell Carcinoma.

737 enrolled

Esophageal Squamous Cell Carcinoma

NCT05945901 2025-11-18

A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer

669 enrolled

Colorectal Neoplasms

NCT05033522 2025-10-23

ALIVE

Phase 2/3 Suspended

150 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07219238 2025-10-21

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

GastrointestinalGynecologic

175 enrolled

Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT05980481 2025-09-29

A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer

201 enrolled

Stomach Neoplasms

NCT07165886 2025-09-10

Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

EndocrineGastrointestinalNET

243 enrolled

Gastroenteropancreatic Neuroendocrine Tumors

NCT05149807 2025-08-20

Clinical Study of SHR-1701 Plus Chemotherapy as Perioperative Treatment in Subjects With Gastric Cancer

81 enrolled

Perioperative Treatment in Subjects With Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Cancer

NCT06109272 2025-08-15

LIVIGNO-2

660 enrolled

Carcinoma, Hepatocellular

NCT05002127 2025-08-07

A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

127 enrolled

Stomach Neoplasms

NCT04082364 2025-06-08

MAHOGANY

82 enrolled 22 charts

Stomach Neoplasms

NCT04856787 2025-05-18

A Clinical Studyf of SHR-1701 or Placebo in Combination With BP102 and XELOX in the First-line Treatment of mCRC

62 enrolled

Colorectal Neoplasms

NCT05141721 2025-05-16

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

700 enrolled

Colorectal Neoplasms

NCT02807181 2025-05-09

SIRCCA

89 enrolled 23 charts

Cholangiocarcinoma

NCT05065957 2025-04-30

Study of Combination Therapy of D07001-Softgel Capsules and Xeloda/TS-1 in Subjects With Advanced Biliary Tract Cancer

180 enrolled

Biliary Tract Neoplasms

NCT05506943 2025-04-20

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

150 enrolled

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT01249352 2025-03-31

NICE

104 enrolled

Adenocarcinoma, Esophageal Neoplasms

NCT04499924 2025-01-22

MOUNTAINEER-02

17 enrolled 23 charts

Adenocarcinoma Of Esophagus

NCT06504732 2025-01-20

To Evaluate IAH0968 in Combination With CAPEOX in HER2-positive Gastric Cancer

90 enrolled

Stomach Neoplasms

NCT03512756 2024-11-06

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

130 enrolled 13 charts

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT05254171 2024-11-06

ASPIRE

600 enrolled

Pancreatic Neoplasms

NCT04547166 2024-10-17

A Clinical Study to Evaluate Efficacy and Safety of Serplulimab（HLX10） Combined With Bevacizumab（HLX04) and Chemotherapy (XELOX) in Patients With Metastatic Colorectal Cancer (mCRC)

568 enrolled

Colorectal Neoplasms

NCT06079346 2024-08-13

STOP-PC

455 enrolled

Pancreatic Ductal Adenocarcinoma

NCT00113256 2024-08-02

Orathecin + Gemcitabine Versus Placebo + Gemcitabine in Chemonaive Non-Resectable Pancreatic Cancer

39 enrolled

Adenocarcinoma, Pancreatic Neoplasms

NCT02746796 2024-05-03

Study of ONO-4538 in Gastric Cancer

680 enrolled

Stomach Neoplasms

NCT03721744 2024-04-03

A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic Cancer

336 enrolled

Pancreatic Neoplasms

NCT06221748 2024-04-03

DV Combined With Cadonilimab in Subjects With HER2-expressing Gastric Cancer and Gastroesophageal Junction Adenocarcinoma After Progression on First-line Therapy

90 enrolled

Stomach Neoplasms

NCT04560894 2024-02-01

HCC

Phase 2/3 Unknown

405 enrolled

Carcinoma, Hepatocellular

NCT05427383 2023-12-19

KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line Therapy

286 enrolled

Stomach Neoplasms

NCT03414983 2023-11-18

CheckMate 9X8

196 enrolled 26 charts

Colorectal Neoplasms

NCT04066491 2023-11-14

Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC

309 enrolled 17 charts

Biliary Tract Neoplasms, Camurati-Engelmann Syndrome, Gallbladder Neoplasms, Cholangiocarcinoma

NCT05976568 2023-08-04

A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma

668 enrolled

Carcinoma, Hepatocellular

NCT05408221 2023-03-10

HCC

576 enrolled

Carcinoma, Hepatocellular

NCT05429697 2022-09-27

Study of SMT-NK Inj. Plus Pembrolizumab vs Pembrolizumab Monotherapy in Patients With Advanced Biliary Tract Cancer

128 enrolled

Biliary Tract Neoplasms, Cholangiocarcinoma

NCT04037241 2022-04-01

Study of Anti-CEA CAR-T + Chemotherapy VS Chemotherapy Alone in Patients With CEA+Pancreatic Cancer & Liver Metastases

Phase 2/3 Withdrawn

Malignant Tumor of Pancreas Metastatic to Liver

NCT03086993 2022-03-24

Percutaneous Hepatic Perfusion vs. Cisplatin/Gemcitabine in Patients With Intrahepatic Cholangiocarcinoma

Phase 2/3 Unknown

295 enrolled